Paz Ribas

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

María‐Victoria Mateos, JoséM. Hernández, M.B. Gómez Hernández et al. · Blood · 2006 · 389 citations · Full text

Medicine, Hematology, Oncology +15

Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

Enric Carreras, Laura Rosiñol, María José Terol et al. · Biology of Blood and Marrow Transplantation · 2007 · 92 citations · Full text

Medicine, Hematology, Oncology +16

Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach

Margarita Blanes, Juan José Lahuerta, José D. González et al. · Biology of Blood and Marrow Transplantation · 2012 · 76 citations · Full text

Medicine, Oncology, Pharmacology +13

Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Sandy W. Wong, Noffar Bar, Laura París et al. · Blood · 2022 · 68 citations

Medicine, Immunology, Oncology +14

Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.

Luís Larrea, Javier de la Rubia, María Angeles Soler et al. · PubMed · 2004 · 33 citations

Life Sciences, Microbiology, Bacteriology +12